As of 2025-09-18, the Relative Valuation of MEI Pharma Inc (MEIP) is (2.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.07 USD, the upside of MEI Pharma Inc based on Relative Valuation is -190.1%.
The range of the Relative Valuation is (8.53) - 5.99 USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.3x - 15.5x | 13.9x |
| Forward P/E multiples | 12.4x - 20.1x | 13.8x |
| Fair Price | (8.53) - 5.99 | (2.77) |
| Upside | -377.8% - 95.0% | -190.1% |
| Date | P/E |
| 2025-09-17 | -3.76 |
| 2025-09-16 | -3.88 |
| 2025-09-15 | -4.20 |
| 2025-09-12 | -4.23 |
| 2025-09-11 | -4.57 |
| 2025-09-10 | -4.43 |
| 2025-09-09 | -4.01 |
| 2025-09-08 | -4.33 |
| 2025-09-05 | -6.10 |
| 2025-09-04 | -6.16 |
| 2025-09-03 | -6.53 |
| 2025-09-02 | -7.00 |
| 2025-08-29 | -7.01 |
| 2025-08-28 | -7.50 |
| 2025-08-27 | -7.44 |
| 2025-08-26 | -7.62 |
| 2025-08-25 | -7.21 |
| 2025-08-22 | -7.17 |
| 2025-08-21 | -6.66 |
| 2025-08-20 | -6.62 |
| 2025-08-19 | -6.75 |
| 2025-08-18 | -7.04 |
| 2025-08-15 | -7.05 |
| 2025-08-14 | -7.07 |
| 2025-08-13 | -7.41 |
| 2025-08-12 | -6.91 |
| 2025-08-11 | -6.97 |
| 2025-08-08 | -7.49 |
| 2025-08-07 | -7.36 |
| 2025-08-06 | -7.18 |
| 2025-08-05 | -7.28 |
| 2025-08-04 | -7.39 |
| 2025-08-01 | -7.02 |
| 2025-07-31 | -7.43 |
| 2025-07-30 | -7.28 |
| 2025-07-29 | -7.28 |
| 2025-07-28 | -8.58 |
| 2025-07-25 | -9.72 |
| 2025-07-24 | -9.52 |
| 2025-07-23 | -8.94 |
| 2025-07-22 | -9.90 |
| 2025-07-21 | -9.45 |
| 2025-07-18 | -8.54 |
| 2025-07-17 | -6.49 |
| 2025-07-16 | -5.57 |
| 2025-07-15 | -4.43 |
| 2025-07-14 | -4.24 |
| 2025-07-11 | -3.88 |
| 2025-07-10 | -3.88 |
| 2025-07-09 | -3.97 |